Cardiac hypertrophy alters myocardial response to ischaemia and reperfusion in vivo

L L Ji1, R G Fu, E W Mitchell

  • 1Department of Kinesiology, University of Illinois, Urbana 61801.

Insights

Cardiac hypertrophy, induced by aortic constriction or swimming, protected rat hearts against ischemia-reperfusion injury. Hypertrophied hearts showed better antioxidant status and energy metabolism, indicating enhanced resistance to I-R damage.

Area of Science:

  • Cardiovascular Physiology
  • Biochemistry
  • Oxidative Stress

Background:

  • Cardiac hypertrophy can alter myocardial response to stress.
  • Ischemia-reperfusion (I-R) injury is a critical concern in cardiovascular disease.
  • Understanding protective mechanisms in hypertrophied hearts is vital.

Purpose of the Study:

  • To investigate the impact of cardiac hypertrophy on myocardial biochemical and physiological responses to I-R.
  • To compare the effects of different hypertrophy models (aortic constriction vs. swimming training) on I-R tolerance.
  • To assess oxidative and antioxidant status, and energy metabolism during I-R in hypertrophied hearts.

Main Methods:

  • Cardiac hypertrophy was induced in rats via aortic constriction (PH) or swimming training (TH).
  • Open-chest rat hearts underwent 30 min ischemia followed by 15 min reperfusion (I-R) or sham operation.
  • Myocardial biochemical markers (glutathione, ATP, adenine nucleotides) and physiological parameters (heart rate, pressure) were measured.

Main Results:

  • I-R significantly depleted glutathione (GSH) and reduced the GSH/GSSG ratio in control hearts, alongside decreased ATP and energy charge.
  • Hypertrophied hearts (PH and TH) showed no significant alterations in GSH status or adenine nucleotide metabolism post-I-R.
  • TH rats exhibited preserved heart rate, peak systolic pressure, and energy charge during I-R compared to controls.

Conclusions:

  • Well-functioning hypertrophied hearts demonstrate resistance to I-R-induced disturbances in oxidative and antioxidant functions.
  • Hypertrophy may confer cardioprotection against I-R injury by maintaining cellular redox balance and energy homeostasis.
  • These findings suggest potential therapeutic strategies targeting hypertrophy-related protective pathways.

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...